SUZHOU, China, July 28, 2025 /PRNewswire/ -- XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. achieved a significant milestone in its "world's first" China NMPA & US FDA-approved registrational clinical trial. This Phase I China registrational clinical trial for XS228 Cell Injection – the world's first "off-the-shelf", allogeneic, iPSC-derived, spinal neural progenitor cell therapy targeting major neurological...
CHANGZHOU, China, Jan. 14, 2025 /PRNewswire/ -- Arctech, the world's leading solar tracking and racking solutions provider, announced that it had signed a supply...
LAS VEGAS, Jan. 14, 2025 /PRNewswire/ -- During CES 2025, Microsoft Greater China held a specialized event themed "Be AI Ready, Win Globally," focusing...
MANILA, Philippines, Jan. 14, 2025 /PRNewswire/ -- UNI-PIPC (UNI-President Information Philippines Corp.), a new IT solutions provider and subsidiary of Uni-President Group., today announced...
Local artist Vika Cheng meticulously designed and handcrafted giant paper coloured carp to send blessings to the public
The installation features interactive...
KUALA LUMPUR, Malaysia, Jan. 14, 2025 /PRNewswire/ -- The Malaysian Society for Quality in Health (MSQH), a leading national healthcare accreditation body dedicated to...